Curis Inc (CRIS)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$0.8299−$0.0494 (−5.62%) on the dayAs of the close; data may be delayed.
CRIS price, last 12 months
Key stats
- Previous close
- $0.8793
- Open
- $0.8977
- Day range
- $0.8096 – $0.9598
- 52-week range
- $0.8096 – $34.80
- Volume
- 290.5K
- Avg volume (20 days)
- 148.5K
- Market cap
- $2.0M
Performance
1W−17.0%
1M−46.1%
3M−87.1%
6M−92.9%
YTD−95.8%
1Y−97.5%
vs S&P 500, 1Y−114.3 pts
Technicals and fundamentals
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $2.0M